Senseonics Holdings (SENS) Shares Outstanding (Weighted Average) (2014 - 2026)
Senseonics Holdings (SENS) reported Shares Outstanding (Weighted Average) of $45.8 million for Q1 2026, up 27.48% year-over-year from $35.9 million in Q1 2025, and up 9.81% quarter-over-quarter from $41.7 million in Q4 2025.
Senseonics Holdings (SENS) Shares Outstanding (Weighted Average) (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Shares Outstanding (Weighted Average) data on file, last reported at $45.8 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $45.8 million, up 27.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.8 million (up 27.48% YoY), and the FY2025 annual result was $41.7 million, up 32.53% from the prior year.
- Shares Outstanding (Weighted Average) advanced to $45.8 million in Q1 2026 per SENS's latest filing, from $41.7 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $766.4 million in Q2 2025 and troughed at $30.9 million in Q3 2024.
- A 5-year average of $368.5 million and a median of $464.2 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) slumped 94.46% in 2024, then soared 45.63% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $468.0 million in 2022, then rose by 21.37% to $568.0 million in 2023, then tumbled by 94.46% to $31.5 million in 2024, then surged by 32.53% to $41.7 million in 2025, then grew by 9.81% to $45.8 million in 2026.
- Business Quant data shows SENS's Shares Outstanding (Weighted Average) at $45.8 million in Q1 2026, $41.7 million in Q4 2025, and $45.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Senseonics Holdings | 309.99 Mn | 245.67 Mn | 6.94 Mn | 45.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.82 Mn |
| Dec 31, 2025 | 41.73 Mn |
| Sep 30, 2025 | 44.95 Mn |
| Jun 30, 2025 | 766.38 Mn |
| Mar 31, 2025 | 35.94 Mn |
| Dec 31, 2024 | 31.49 Mn |
| Sep 30, 2024 | 30.87 Mn |
| Jun 30, 2024 | 615.59 Mn |
| Mar 31, 2024 | 614.59 Mn |
| Dec 31, 2023 | 567.97 Mn |
| Sep 30, 2023 | 552.70 Mn |
| Jun 30, 2023 | 567.13 Mn |
| Mar 31, 2023 | 497.47 Mn |
| Dec 31, 2022 | 467.95 Mn |
| Sep 30, 2022 | 464.24 Mn |
| Jun 30, 2022 | 464.13 Mn |
| Mar 31, 2022 | 455.94 Mn |
| Dec 31, 2021 | 422.32 Mn |
| Sep 30, 2021 | 414.13 Mn |
| Jun 30, 2021 | 398.24 Mn |